Massive Bio is selected as the Best in Class Quarterfinalist by The Digital Health Hub Foundation
Selin Kurnaz posted on LinkedIn:
“Massive Bio is selected as the Best in Class Quarterfinalist in Health Equity Category by The Digital Health Hub Foundation – Digital Health Awards. We are extremely proud of this major accomplishment. I would like to thank the Foundation as well as my rockstar team to make this happen. Especially Health Equity category means a lot to us as we have seen the bottlenecks and felt that something should be done to increase health equity and access much earlier than any other company in the space.
Summer has been incredibly busy and it is already looking that Fall is going to be another record breaking quarter for Massive Bio. Please watch out for some big announcements that have lined up starting ESMO2024.
At Massive Bio, we move mountains every single day to support cancer patients to get access to clinical trials and obviously these types of acknowledgements that we get through awards put a little smile on our face.
Many many more to come, we are just starting.”
Source: Selin Kurnaz/LinkedIn
Selin Kurnaz is the Co-Founder and CEO of Massive Bio. She also serves as an Investment Steering Committee Member at Volitan Ventures Club and Volitan Global. Her interests include energy, transportation, and the intersection of mathematics and technology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023